BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38651500)

  • 21. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
    Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
    Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FLT3 expression and IL10 promoter polymorphism in acute myeloid leukemia with RUNX1-RUNX1T1.
    Kim M; Kim J; Kim JR; Han E; Park J; Lim J; Kim Y; Han K; Kim HJ; Min WS; Cho B
    Mol Biol Rep; 2015 Feb; 42(2):451-6. PubMed ID: 25287662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia.
    Qin YZ; Jiang Q; Wang Y; Jiang H; Xu LP; Zhao XS; Zhang XH; Liu KY; Huang XJ
    Blood Cancer J; 2021 Apr; 11(4):67. PubMed ID: 33795645
    [No Abstract]   [Full Text] [Related]  

  • 24. Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22).
    Yao H; Pan J; Wu C; Shen H; Xie J; Wang Q; Wen L; Wang Q; Ma L; Wu L; Ping N; Zhao Y; Sun A; Chen S
    Mol Cancer; 2015 Apr; 14():81. PubMed ID: 25879624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group.
    Paschka P; Schlenk RF; Gaidzik VI; Herzig JK; Aulitzky T; Bullinger L; Späth D; Teleanu V; Kündgen A; Köhne CH; Brossart P; Held G; Horst HA; Ringhoffer M; Götze K; Nachbaur D; Kindler T; Heuser M; Thol F; Ganser A; Döhner H; Döhner K
    Haematologica; 2015 Mar; 100(3):324-30. PubMed ID: 25596267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two childhood cases of acute leukemia with t(16;21)(p11.2;q22): second case report of infantile acute lymphoblastic leukemia with unusual type of FUS-ERG chimeric transcript.
    Oh SH; Park TS; Choi JR; Lee S; Cho SY; Kim SY; Kim J; Park JK; Song SA; Lee JY; Shin JH; Kim HR; Lee JN
    Cancer Genet Cytogenet; 2010 Jul; 200(2):180-3. PubMed ID: 20620604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The First Case of Acute Myeloid Leukemia With a Novel Five-way Variant Translocation of
    Jo YH; Han EA; Park SK; Jeon BR; Jang MA
    Ann Lab Med; 2023 May; 43(3):315-318. PubMed ID: 36544347
    [No Abstract]   [Full Text] [Related]  

  • 28. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal residual disease-directed therapy in acute myeloid leukemia.
    Kayser S; Schlenk RF; Grimwade D; Yosuico VE; Walter RB
    Blood; 2015 Apr; 125(15):2331-5. PubMed ID: 25631772
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute myeloid leukemia (aml) subtype M2 with variation of the t (8;21)translocation and AML1/ETO expression].
    Llimpe Y; Monteza R; Ticlahuanca J; Rubio P; Ortíz C; Arias A
    Rev Peru Med Exp Salud Publica; 2013 Mar; 30(1):145-6. PubMed ID: 23612831
    [No Abstract]   [Full Text] [Related]  

  • 31. [The study of clinical characteristics and prognosis of RUNX1-RUNX1T1 positive acute myeloid leukemia based on next-generation sequencing].
    Wang YL; Gao SJ; Su L; Liu YJ; Zhang YW; Du YZ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):851-854. PubMed ID: 38049338
    [No Abstract]   [Full Text] [Related]  

  • 32. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Four-Way t(8;14;15;21)(q22;q22;q15;q22.1) Translocation Variant in Acute Myeloid Leukemia with
    Tsuge N; Ogasawara F; Kondo T; Yoshida S; Kojima K
    Turk J Haematol; 2024 May; 41(2):128-129. PubMed ID: 38488305
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypereosinophilia with a low blast count as the initial manifestation of acute myeloid leukaemia with RUNX1-RUNX1T1.
    Stussi G; Tichelli A; Schanz U; Goede J
    Br J Haematol; 2009 Aug; 146(4):346. PubMed ID: 19388941
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1.
    Wei H; Liu X; Wang Y; Lin D; Zhou C; Liu B; Qiu S; Gu R; Li Y; Wei S; Gong B; Liu K; Gong X; Liu Y; Zhang G; Fang Q; Zhang J; Jin J; Ma Y; Mi Y; Wang J
    Exp Hematol; 2021 Apr; 96():63-72.e3. PubMed ID: 33524443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of c-KIT mutations on expression of the RUNX1/RUNX1T1 fusion transcript in t(8;21)-positive acute myeloid leukemia patients.
    Park SH; Chi HS; Cho YU; Jang S; Park CJ
    Leuk Res; 2013 Jul; 37(7):784-9. PubMed ID: 23528260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some novel features of IDH1-mutated acute myeloid leukemia revealed in Chinese patients.
    Zhang Y; Wei H; Wang M; Huai L; Mi Y; Zhang Y; Lin D; Liu B; Li W; Zhou C; Rao Q; Wang J
    Leuk Res; 2011 Oct; 35(10):1301-6. PubMed ID: 21316759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FACSorting help to analyze a rare case of acute myeloid leukemia with concurrent AML1-ETO and PML-RARA.
    Chen M; Fu M; Wang A; Wu X; Zhen J; Gong M; Wu P; Du Q; Wang T; Liu H; Wang H
    Int J Lab Hematol; 2021 Dec; 43(6):e276-e279. PubMed ID: 33943002
    [No Abstract]   [Full Text] [Related]  

  • 39. RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
    Greif PA; Konstandin NP; Metzeler KH; Herold T; Pasalic Z; Ksienzyk B; Dufour A; Schneider F; Schneider S; Kakadia PM; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
    Haematologica; 2012 Dec; 97(12):1909-15. PubMed ID: 22689681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and clinical impact of ETV6/RUNX1, AF4-MLL, and BCR/ABL fusion genes on features of acute lymphoblastic leukemia at presentation.
    Ajuba IC; Madu AJ; Okocha C; Ibegbulam OG; Okpala I; Nna OE
    Niger J Clin Pract; 2016; 19(2):237-41. PubMed ID: 26856288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.